These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 35043)

  • 21. Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats.
    Gratton JP; Maurice MC; Rae GA; D'Orléans-Juste P
    Am J Hypertens; 1995 Nov; 8(11):1121-7. PubMed ID: 8554736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for bradykinin potentiation by angiotensin congeners in conscious rats.
    Textor SC; Brunner H; Gavras H
    Am J Physiol; 1981 Feb; 240(2):H255-61. PubMed ID: 6258451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ketamine, halothane, enflurane, and isoflurane on systemic and splanchnic hemodynamics in normovolemic and hypovolemic cirrhotic rats.
    Debaene B; Goldfarb G; Braillon A; Jolis P; Lebrec D
    Anesthesiology; 1990 Jul; 73(1):118-24. PubMed ID: 2360721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chronic hypoxia on angiotensin-induced pulmonary vasoconstriction and converting enzyme activity in the rat.
    Caldwell RW; Blatteis CM
    Proc Soc Exp Biol Med; 1983 Mar; 172(3):346-50. PubMed ID: 6302709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of angiotensin-converting enzyme inhibitors in the rat in perfused hindlimbs and in vivo.
    Nelissen-Vrancken MH; Leenders PJ; Bost JG; Struijker-Boudier HA; Smits JF
    Eur J Pharmacol; 1992 Jun; 217(1):49-55. PubMed ID: 1327817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic treatment with quercetin does not inhibit angiotensin-converting enzyme in vivo or in vitro.
    Neto-Neves EM; Montenegro MF; Dias-Junior CA; Spiller F; Kanashiro A; Tanus-Santos JE
    Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):825-9. PubMed ID: 20406213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-induced inhibition of converting enzyme activity: role in vascular regulation.
    Jin H; Oparil S; Ann HS; Yang R; Jackson RM
    J Appl Physiol (1985); 1987 Sep; 63(3):1012-8. PubMed ID: 2820918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs.
    Harris DN; Heran CL; Goldenberg HJ; High JP; Laffan RJ; Rubin B; Antonaccio MJ; Goldberg ME
    Eur J Pharmacol; 1978 Oct; 51(4):345-9. PubMed ID: 213295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
    Schunkert H; Jackson B; Tang SS; Schoen FJ; Smits JF; Apstein CS; Lorell BH
    Circulation; 1993 Apr; 87(4):1328-39. PubMed ID: 8384939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of respiratory acidosis on the arrhythmia threshold during fluroxene and halothane anesthesia.
    Eikard B; Skovsted P
    Acta Anaesthesiol Scand; 1975; 19(2):120-6. PubMed ID: 237395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.
    Lembeck F; Griesbacher T; Eckhardt M
    Br J Pharmacol; 1990 May; 100(1):49-54. PubMed ID: 2164861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors.
    Riegger AJ; Lever AF; Millar JA; Morton JJ; Slack B
    Lancet; 1977 Dec 24-31; 2(8052-8053):1317-9. PubMed ID: 74729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
    Burton J; Cody RJ; Herd JA; Haber E
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5476-9. PubMed ID: 6159648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renin release, an artifact of anesthesia and its implications in rats.
    Pettinger WA; Tanaka K; Keeton K; Campbell WB; Brooks SN
    Proc Soc Exp Biol Med; 1975 Mar; 148(3):625-30. PubMed ID: 1129282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between angiotensin II, sympathetic nerve-mediated pressor response and cyclo-oxygenase products in the pithed rat.
    Grant TL; McGrath JC
    Br J Pharmacol; 1988 Dec; 95(4):1220-8. PubMed ID: 3146400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of angiotensin converting enzyme inhibitors. A review.
    Nelson EB; Pool JL; Taylor AA
    Am J Med; 1986 Oct; 81(4C):13-8. PubMed ID: 3022580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct effects in vivo of angiotensins I and II on the canine sinus node.
    Lambert C; Godin D; Fortier P; Nadeau R
    Can J Physiol Pharmacol; 1991 Mar; 69(3):389-92. PubMed ID: 1676339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The bladder angiotensin system in female rats: response to infusions of angiotensin I and the angiotensin converting enzyme inhibitor enalaprilat.
    Weaver-Osterholtz D; Reams G; De Vergel CF; Bauer JH
    J Urol; 2001 May; 165(5):1735-8. PubMed ID: 11342966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
    Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
    Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.